Atlas Trials

Master Rollover Protocol for Continued Safety Assessment of Study Drug

Clinical trial NCT02632994 · AVAILABLE

Trial details

NCT number
NCT02632994
Sponsor
Eli Lilly and Company
Status
AVAILABLE
Study type
EXPANDED_ACCESS
Cancer

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.